On May 28, the General Health Council (CSG, in Spanish) announced that it is working on the development of a National Pharmaceutical Strategy to facilitate access to medicines for the Mexican population. The CSG will hold dialogue tables between June and September to gather opinions for drafting the text, with a view to its publication and entry into force in the first half of 2022. With a view to implementing more measures for access to medicines, on May 27 President Andrés Manuel López Obrador (AMLO) announced the purchase of oncology drugs from South Korea, Germany, Cuba and Argentina. The President’s objective is to guarantee access to these drugs, especially for minors suffering from cancer.
Regarding the National Pharmaceutical Strategy, the technical secretary of the CSG, Alberto Gómez, mentioned a road map to elaborate the application scheme of the strategy for innovation and financing of medicines, made up of seven work tables that will operate between June and September. After these tables, between August and November, the objectives of the pharmaceutical plan will be defined with the inputs collected. In this way, they estimate that after the first draft is written in January 2022, the strategy will be approved between March and May of the same year.
Regarding AMLO’s announcement, the President assured that “the contracts have already been signed, the oncological medicines have already been purchased, they will not be lacking, and I repeat, they were purchased in South Korea, Germany, Cuba and Argentina”. At the same time, he declared that the medicines “are already arriving to the country” and “will be enough for the rest of the year”.